4//SEC Filing
Wigzell Hans Lennart Rudolf 4
Accession 0000950170-24-136847
CIK 0000873303other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 8:00 PM ET
Size
8.6 KB
Accession
0000950170-24-136847
Insider Transaction Report
Form 4
Wigzell Hans Lennart Rudolf
Director
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2024-12-12−10,500→ 0 totalExercise: $13.71From: 2017-02-28Exp: 2026-02-28→ Common Stock (10,500 underlying) - Exercise/Conversion
Common Stock
2024-12-12$13.71/sh+10,500$143,955→ 33,340 total - Sale
Common Stock
2024-12-12$124.84/sh−10,500$1,310,820→ 22,840 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.92 to $124.80, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001492766
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 8:00 PM ET
- Size
- 8.6 KB